News and Events

Hatchtech Announces Successful Results from Phase 2 Ovicidal Study

21/10/2014 | Press Releases

21st October 2014, Melbourne Australia

Specialty pharmaceutical company Hatchtech Pty Ltd today announced succesful completion of a Phase 2 clinical trial evaluating the ovicidal efficacy (ability to kill lice eggs) of a single 10 minute application of Xeglyze Lotion developed as a treatment for head lice infestation.